Cytosorbents Corporation
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 23 →Insiders2 insiders bought $148,898 in 3 open-market buys. No sales.→HoldersAvenir 8.3%Neuberger Berman 3.1%Vanguard 3.0%→
From the filings
Figures
- Revenue
- $37.2Mlast 12 months
- Net income
- −$18.2Mlast 12 months
- Operating cash flow
- −$10.1Mlast 12 months
- Cash and equivalents
- $4.4Mat the last balance sheet
- Total debt
- $17.2Mat the last balance sheet
- Shares outstanding
- 62.8M shareson issue